Socioeconomic and global burden of COVID-19

2021

Качественная клиническая практика, Vol 0, Iss 1, Pp 24-34 (2021)

Relevance. Assessment of the burden of disease provides information on the economic consequences of the disease, allows you to assess the social significance, identify areas that require additional clinical and economic research, changes in methodological approaches to the organization of measures for the prevention, early detection and treatment of diseases.The aim. Assessment of the socioeconomic and global burden of COVID-19 in the Russian Federation (RF).Materials and methods. Identification and assessment of direct medical, direct non-medical, and indirect costs associated with the development of the coronavirus epidemic. When calculating the socioeconomic burden, the variant of calculations was chosen taking into account the prevalence of the disease. The sources of data on the epidemiology of the disease were data from the Ministry of Health and data from the Government of the RF.Results. The socioeconomic burden of COVID-19 in 2020 in the RF amounted to about 5.4 trillion rubles (5 % of nominal GDP in 2020) and was largely due to indirect costs due to GDP losses due to a 1.5-month period of self-isolation. The estimated global burden of disease is more than 4 million YLLs globally, of which in the RF 2,486.30 among men and 1,378.22 YLL among women.Conclusion. The epidemic of the new coronavirus infection has led to colossal economic losses in Russian society. The data presented underscore not only the clinical, but also the economic importance of investing in the development of strategies for the treatment and prevention of new coronavirus infection.

article

Russian

Izdatelstvo OKI, 2021.

коронавирус, социально-экономическое бремя, глобальное бремя болезни, анализ стоимости болезни, россия, covid-19, потерянные года жизни, потерянные года жизни из-за инвалидности, Medical technology, R855-855.5, Pharmacy and materia medica, RS1-441